• Products
  • Insights
  • Practice Management
  • Resources
  • About Us

Domestic Equity fund

Hartford Healthcare Fund   

Domestic Equity fund

Hartford Healthcare Fund   
Share Class - Y (HGHYX)

Objective

Seeks long-term capital appreciation.

Overview

A stock fund that invests exclusively in health care, a sector that is experiencing innovations and breakthroughs across multiple subsectors.

Portfolio Management
Senior Managing Director
Global Industry Analyst
3
YRS
MANAGING THIS FUND
17
YRS
AT WELLINGTON MANAGEMENT
19
YRS
EXPERIENCE IN THIS INDUSTRY
Managing Director
Global Industry Analyst
2
YRS
MANAGING THIS FUND
9
YRS
AT WELLINGTON MANAGEMENT
17
YRS
EXPERIENCE IN THIS INDUSTRY
Managing Director
Global Industry Analyst
2
YRS
MANAGING THIS FUND
11
YRS
AT WELLINGTON MANAGEMENT
25
YRS
EXPERIENCE IN THIS INDUSTRY
Managing Director
Global Industry Analyst
2
YRS
MANAGING THIS FUND
13
YRS
AT WELLINGTON MANAGEMENT
13
YRS
EXPERIENCE IN THIS INDUSTRY

The portfolio managers are supported by the full resources of Wellington.

Performance

PERFORMANCE %
 
CUMULATIVE %
(as of 2/29/2024)
AVERAGE ANNUAL TOTAL RETURNS %
(as of 2/29/2024)
YTD 1YR 3YR 5YR 10YR SI
Hartford Healthcare Y 5.21 15.45 2.33 9.25 9.51 11.33
Benchmark 6.06 14.98 9.32 11.15 11.24 ---
Morningstar Health Category 5.27 11.02 -0.81 7.31 8.41 ---
 
CUMULATIVE %
(as of 12/31/2023)
AVERAGE ANNUAL TOTAL RETURNS %
(as of 12/31/2023)
YTD 1YR 3YR 5YR 10YR SI
Hartford Healthcare Y 4.04 4.04 0.51 10.79 10.09 11.17
Benchmark 1.92 1.92 7.15 11.24 11.32 ---
Morningstar Health Category 3.22 3.22 -2.35 8.65 8.95 ---

Performance data quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted.

SI = Since Inception. Fund Inception: 05/01/2000

Hartford Healthcare Fund Y Share Morningstar Ratings
Morningstar Medalist RatingTM
9/29/2023

Characteristics

FUND ESSENTIALS
Inception Date 05/01/2000
Net Assets $1.2 billion
Total Operating Expenses 1.01%
Morningstar Category Health
Lipper Classification Global Health/Biotechnology Funds
CUSIP 416645364
Fund Number 1613
FUND STATS
# of Holdings
100
% in Equities
99
% in Foreign Equities
14
Beta (3 year)
0.97
R Squared (3 year)
0.88
Standard Deviation
15.23%
Turnover- (12/31/2023)
29%
Active Share
47%
Holdings Characteristics
FUND S&P Composite 1500 Health Care Index
Price/Earnings
28.9x 18.5x
Price/Book
5.4x 4.9x
EPS Growth Rate
18.0% 14.4%
Asset Weighted Market Cap (billions)
$188.1 $235.5
Return on Equity
21.3% 32.2%
Median Market Cap (billions)
$10.5 $5.6
Regional Exposure (%)
North America 86
Developed EU & Middle East ex UK 6
United Kingdom 4
Japan 3
Emerging Markets 1
North America 87
Developed EU & Middle East ex UK 5
United Kingdom 4
Japan 3
Emerging Markets 1
Top Ten Holdings (%)
Eli Lilly & Co. 10.89
UnitedHealth Group, Inc. 6.79
Merck & Co., Inc. 6.35
Danaher Corp. 3.90
Stryker Corp. 2.83
Boston Scientific Corp. 2.80
HCA Healthcare, Inc. 2.52
Thermo Fisher Scientific, Inc. 2.52
AbbVie, Inc. 2.39
Vertex Pharmaceuticals, Inc. 2.32
Total Portfolio % 43.31
Market Cap Distribution (%)

Market Cap Header3

Less than $2 billion 3
$2 billion - $5 billion 7
$5 billion - $10 billion 8
Greater than $10 billion 82
Not Classified 0
RETURN CHARACTERISTICS
Alpha (5 Year)
-1.67
Down Capture (5 Year)
104.25
Information Ratio (5 Year)
-0.36
Sharpe Ratio (5 Year)
0.50
Up Capture (5 Year)
96.32
Subsector Exposure
Health Care 100
Biopharma Large Cap 36
Medical Technology 27
Health Care Services 25
Biopharma Mid Cap 9
Biopharma Small Cap 3
Communication Services 0
Consumer Discretionary 0
Consumer Staples 0
Energy 0
Financials 0
Industrials 0
Information Technology 0
Materials 0
Real Estate 0
Utilities 0
Health Care 100
Biopharma Large Cap 34
Medical Technology 27
Health Care Services 26
Biopharma Mid Cap 11
Biopharma Small Cap 2
Industrials 0
Communication Services 0
Consumer Discretionary 0
Consumer Staples 0
Energy 0
Financials 0
Information Technology 0
Materials 0
Real Estate 0
Utilities 0
Based on sub-adviser's classification of health care subsectors, which includes combining biotechnology and pharmaceuticals in terms of capitalization: biopharma small-cap, biopharma mid-cap, and biopharma large-cap. Excludes cash. May not total to 100% due to rounding.
distributions and capital gains
Distribution Date Distribution NAV ordinary income short term capital gains long term capital gains total distribution
12/27/2023 45.11 $0.0000 $0.0000 $0.0000 $0.0000
12/11/2023 43.16 $0.0000 $0.0000 $0.0000 $0.0000
Past distributions are not indicative of future distributions.

Fund Literature


12/31/2023 - PDF (244 KB)
This Fund Fact Sheet summarizes the Fund's investment approach, portfolio statistics, top holdings, and current performance.
12/31/2023 - PDF (140 KB)
Current quarterly commentary from our sub-adviser, Wellington Management, which includes a performance review, attribution, statistics, and positioning and outlook for the Fund.
12/31/2023 - PDF (265 KB)
Current quarterly commentary from our sub-adviser, Wellington Management, which includes a performance review, attribution, statistics, and positioning and outlook for the Fund.
PDF (157 KB)
A summary of a fund's full-length prospectus that provides key information potential investors should consider before making an investment decision.
12/31/2023 - PDF (320 KB)
This Pitchbook reviews the Fund's investment approach, investment team, investment process, and general portfolio parameters.
PDF (3 KB)
An unaudited financial report, which includes a fund's financial statements. These reports are intended for shareholders and others who have reviewed the fund's prospectus.
PDF (13 KB)
A legal document that discloses essential information about a fund, including investment objectives, risks, fees, expenses, fund manager background and other information.
PDF (3 KB)
An audited financial report, which includes a fund's financial statements. These reports are intended for shareholders and others who have reviewed the fund's prospectus.
PDF (13 KB)
A document that supplements the fund's prospectus with additional information about the fund including its operations and risks.
Important Risks: Investing involves risk, including the possible loss of principal. Security prices fluctuate in value depending on general market and economic conditions and the prospects of individual companies. • Risks of focusing investments on the healthcare related sector include regulatory and legal developments, changes in funding or subsidies, patent and intellectual property considerations, intense competitive pressures, rapid technological changes, long and costly process for obtaining product approval by government agencies, potential product obsolescence, rising cost of medical products and services, and price volatility risk. • Small- and mid-cap securities can have greater risks and volatility than large-cap securities. • Foreign investments may be more volatile and less liquid than U.S. investments and are subject to the risk of currency fluctuations and adverse political, economic and regulatory developments. These risks may be greater, and include additional risks, for investments in emerging markets.
3410426

The material on this site is for informational and educational purposes only. The material should not be considered tax or legal advice and is not to be relied on as a forecast. The material is also not a recommendation or advice regarding any particular security, strategy or product. Hartford Funds does not represent that any products or strategies discussed are appropriate for any particular investor so investors should seek their own professional advice before investing. Hartford Funds does not serve as a fiduciary. Content is current as of the publication date or date indicated, and may be superseded by subsequent market and economic conditions.

Investing involves risk, including the possible loss of principal. Investors should carefully consider a fund's investment objectives, risks, charges and expenses. This and other important information is contained in the mutual fund, or ETF summary prospectus and/or prospectus, which can be obtained from a financial professional and should be read carefully before investing.

Mutual funds are distributed by Hartford Funds Distributors, LLC (HFD), Member FINRA|SIPC. ETFs are distributed by ALPS Distributors, Inc. (ALPS). Advisory services may be provided by Hartford Funds Management Company, LLC (HFMC) or its wholly owned subsidiary, Lattice Strategies LLC (Lattice). Certain funds are sub-advised by Wellington Management Company LLP and/or Schroder Investment Management North America Inc (SIMNA). Schroder Investment Management North America Ltd. (SIMNA Ltd) serves as a secondary sub-adviser to certain funds. HFMC, Lattice, Wellington Management, SIMNA, and SIMNA Ltd. are all SEC registered investment advisers. Hartford Funds refers to HFD, Lattice, and HFMC, which are not affiliated with any sub-adviser or ALPS. The funds and other products referred to on this Site may be offered and sold only to persons in the United States and its territories.

© Copyright 2024 Hartford Funds Management Group, Inc. All Rights Reserved. Not FDIC Insured | No Bank Guarantee | May Lose Value